Supreme Court Maintains Telehealth Access for Abortion Pill Mifepristone Amid Legal Challenges
The Supreme Court has issued an order to maintain the availability of the abortion pill mifepristone via telehealth, as a legal case from Louisiana against the Food and Drug Administration (FDA) continues in lower courts. This decision temporarily halts a ruling from the U.S. 5th Circuit Court of Appeals that would have banned the mailing of mifepristone nationwide. The Supreme Court's order, which came slightly past its self-imposed deadline, keeps the current access to medication abortion intact. Justices Samuel Alito and Clarence Thomas dissented, criticizing the decision as undermining the Dobbs ruling, which overturned Roe v. Wade. The case has seen significant involvement from states, with Democratic-led states supporting access to abortion care and Republican-led states backing Louisiana's case. 
